Fund Holdings — Altium Capital Management LLC

Total Portfolio Value:
$321.10M
Total Bought:
$102.27M
Total Sold:
$96.23M
Net Transaction:
+$6.03M
Securities
▲▼
SharesValue
Q3 2024
▲▼
Q4 2024
▲▼
Change
▲▼
Q3 2024
▲▼
Q4 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Adma Biologics Inc1,360,0001,395,000+35,000$27.19M$23.92M7.45%-$3.26M
Vera Therapeutics, Inc.CL A(VERA)684,000432,000-252,000$30.23M$18.27M5.69%-$11.96M
Sarepta Therapeutics, Inc.(SRPT)170,000127,000-43,000$21.23M$15.44M4.81%-$5.79M
Zevra Therapeutics, Inc.(ZVRA)1,700,0001,850,000+150,000$11.80M$15.43M4.81%+$3.63M
Establishment Labs Holdings Inc.(ESTA)131,000305,000+174,000$5.67M$14.05M4.38%+$8.38M
Edwards Lifesciences Corp222,000165,000-57,000$14.65M$12.21M3.80%-$2.43M
Xenon Pharmaceuticals Inc.(XENE)360,600288,000-72,600$14.20M$11.29M3.52%-$2.91M
Soleno Therapeutics Inc212,909250,000+37,091$10.75M$11.24M3.50%+$487.7K
Capricor Therapeutics, Inc.(CAPR)285,000714,000+429,000$4.33M$9.85M3.07%+$5.52M
RxSight, Inc.(RXST)112,000285,000+173,000$5.54M$9.80M3.05%+$4.26M
Merit Medical Systems, Inc.(MMSI)85,000100,000+15,000$8.40M$9.67M3.01%+$1.27M
Biohaven Ltd.(BHVN)75,000250,000+175,000$3.75M$9.34M2.91%+$5.59M
Insmed Incorporated(INSM)130,000132,000+2,000$9.49M$9.11M2.84%-$376.7K
Rezolute, Inc.(RZLT)1,700,0001,694,000-6,000$8.24M$8.30M2.59%+$55.6K
Evolus, Inc.(EOLS)355,000685,000+330,000$5.75M$7.56M2.36%+$1.81M
Intra-Cellular Therapies Inc154,00075,000-79,000$11.27M$6.26M1.95%-$5.00M
argenx SEADR(ARGX)010,000+10,000$0$6.15M1.92%+$6.15M
Glaukos Corporation(GKOS)77,00040,000-37,000$10.03M$6.00M1.87%-$4.03M
ResMed Inc.(RMD)026,000+26,000$0$5.95M1.85%+$5.95M
Viking Therapeutics, Inc.(VKTX)126,000146,000+20,000$7.98M$5.88M1.83%-$2.10M
Endeavour Silver Corp.(EXK)0100,000+100,000$0$5.62M1.75%+$5.62M
Pulmonx Corporation(LUNG)500,000815,000+315,000$4.14M$5.53M1.72%+$1.39M
COMPASS Pathways plcADS(CMPS)01,424,400+1,424,400$0$5.38M1.68%+$5.38M
Catalyst Pharmaceuticals Inc385,000255,000-130,000$7.65M$5.32M1.66%-$2.33M
Contineum Therapeutics, Inc.CL A(CTNM)369,126334,000-35,126$7.07M$4.89M1.52%-$2.17M
Syndax Pharmaceuticals, Inc.(SNDX)0370,000+370,000$0$4.89M1.52%+$4.89M
Savara Inc.(SVRA)1,575,0001,579,000+4,000$6.68M$4.85M1.51%-$1.83M
Avadel Pharmaceuticals Plc610,000452,475-157,525$8.00M$4.76M1.48%-$3.24M
Corbus Pharmaceuticals Holdings, Inc.(CRBP)195,000385,000+190,000$4.02M$4.54M1.41%+$520.1K
Arrowhead Pharmaceuticals, Inc.(ARWR)355,000230,257-124,743$6.88M$4.33M1.35%-$2.55M
Anteris Technologies Global Corp.(AVR)0737,000+737,000$0$4.11M1.28%+$4.11M
Profound Medical Corp.(PROF)0485,000+485,000$0$3.64M1.13%+$3.64M
Xtant Medical Holdings, Inc.(XTNT)7,415,4137,415,4130$5.01M$3.29M1.02%-$1.73M
Skye Bioscience, Inc.(SKYE)1,315,1461,139,000-176,146$5.14M$3.22M1.00%-$1.92M
ORIC Pharmaceuticals, Inc.(ORIC)355,000355,0000$3.64M$2.86M0.89%-$773.9K
TG Therapeutics, Inc.(TGTX)095,000+95,000$0$2.86M0.89%+$2.86M
Nektar Therapeutics(NKTR)11,4193,000,000+2,988,581$14.8K$2.79M0.87%+$2.78M
Keros Therapeutics, Inc.(KROS)69,000175,000+106,000$4.01M$2.77M0.86%-$1.24M
ImmunityBio, Inc.(IBRX)01,060,000+1,060,000$0$2.71M0.85%+$2.71M
Lexeo Therapeutics, Inc.(LXEO)0405,000+405,000$0$2.66M0.83%+$2.66M
Terns Pharmaceuticals Inc330,000475,000+145,000$2.75M$2.63M0.82%-$120.7K
Revolution Medicines, Inc.(RVMD)060,000+60,000$0$2.62M0.82%+$2.62M
Essa Pharma Inc01,428,000+1,428,000$0$2.56M0.80%+$2.56M
Alphatec Holdings, Inc.(ATEC)0264,562+264,562$0$2.43M0.76%+$2.43M
Larimar Therapeutics, Inc.(LRMR)693,000505,000-188,000$4.54M$1.95M0.61%-$2.58M
OnKure Therapeutics, Inc.CL A(OKUR)0218,386+218,386$0$1.88M0.58%+$1.88M
Alpha Cognition Inc. Common Stock(ACOG)0275,000+275,000$0$1.62M0.50%+$1.62M
Proqr Thrapeutics N VSHS EURO
SHS EURO
0575,000+575,000$0$1.52M0.47%+$1.52M
Veru Inc.(VERU)2,028,5342,028,5340$1.56M$1.32M0.41%-$240.4K
Unicycive Therapeutics Inc1,473,0001,473,0000$600.8K$1.17M0.36%+$569.0K
enVVeno Medical Corporation(NVNO)238,920310,000+71,080$802.8K$936.2K0.29%+$133.4K
Bicycle Therapeutics PlcADS85,00040,352-44,648$1.92M$564.9K0.18%-$1.36M
Promis Neurosciences Inc581,395581,3950$726.7K$551.0K0.17%-$175.7K
Fulcrum Therapeutics, Inc.(FULC)0111,812+111,812$0$525.5K0.16%+$525.5K
Karyopharm Therapeutics Inc.(KPTI)740,000740,0000$614.2K$500.5K0.16%-$113.7K
CytomX Therapeutics, Inc.(CTMX)915,000467,491-447,509$1.08M$481.5K0.15%-$598.2K
Perspective Therapeutics, Inc.(CATX)290,00092,224-197,776$3.87M$294.2K0.09%-$3.58M
SRX Global Inc.(SRXH)133,117118,459-14,658$278.2K$278.4K0.09%+$164
Anaptysbio Inc018,326+18,326$0$242.6K0.08%+$242.6K
Quoin Pharmaceuticals LtdADS0282,249+282,249$0$183.7K0.06%+$183.7K
Cellectar Biosciences, Inc.(CLRB)215,000215,0000$460.1K$64.3K0.02%-$395.8K
AtriCure, Inc.(ATRC)54,0000-54,000$1.51M$0—-$1.51M
Axsome Therapeutics, Inc.(AXSM)58,0000-58,000$5.21M$0—-$5.21M
Bitcoin Depot IncW EXP 06 30 20250,0000-50,000$2.5K$0—-$2.5K
BNB Standard CorporationW EXP 02 11 202(BNC)250,0000-250,000$6.3K$0—-$6.3K
Cingulate Inc.W EXP 12 10 202(CING)270,0000-270,000$18.7K$0—-$18.7K
Coliseum Acquisition CorpW EXP 08 22 20228,3330-28,333$1.4K$0—-$1.4K
CDT Equity Inc.W EXP 09 22 202(CDT)100,0000-100,000$1.6K$0—-$1.6K
Cybin D/B/A Helus Pharma(HELP)317,0000-317,000$2.82M$0—-$2.82M
Expion Energy, Inc.(XPON)2,057,4940-2,057,494$106.4K$0—-$106.4K
Fat Brands IncW EXP 07 16 202200,0000-200,000$499.0K$0—-$499.0K
iRhythm Holdings, Inc.(IRTC)86,0000-86,000$6.38M$0—-$6.38M
Nexera Technologies LtdW EXP 99 99 999(NEXR)68,6810-68,681$2.4K$0—-$2.4K
Milestone Pharmaceuticals Inc.(MIST)440,0000-440,000$668.8K$0—-$668.8K
Mobix Labs, Inc.W EXP 99 99 999(MOBX)150,0000-150,000$22.3K$0—-$22.3K
MoonLake ImmunotherapeuticsCL A(MLTX)40,0000-40,000$2.02M$0—-$2.02M
Nexalin Technology IncW EXP 99 99 999105,0000-105,000$8.4K$0—-$8.4K
Nexgel IncW EXP 12 01 202225,0000-225,000$91.5K$0—-$91.5K
Nls Pharmaceutics LtdW EXP 02 02 202200,0000-200,000$2.3K$0—-$2.3K
Ocugen, Inc.(OCGN)2,350,0000-2,350,000$2.33M$0—-$2.33M
Onfolio Holdings, Inc.W EXP 01 02 202(ONFO)200,0000-200,000$34.0K$0—-$34.0K
Outlook Therapeutics, Inc.(OTLK)541,5490-541,549$2.89M$0—-$2.89M
Rocket Pharmaceuticals, Inc.W EXP 09 02 202(RCKT)731,5610-731,561$51.2K$0—-$51.2K
Scorpius Holdings Inc88,2910-88,291$63.6K$0—-$63.6K
Structure Therapeutics IncADS70,0000-70,000$3.07M$0—-$3.07M
Surrozen, Inc.W EXP 08 01 203(SRZN)82,2330-82,233$1.0K$0—-$1.0K
Tc Biopharm Holdings PlcW EXP 02 10 20218,8230-18,823$343$0—-$343
Tempest Therapeutics, Inc.(TPST)545,0000-545,000$763.0K$0—-$763.0K
The RealReal, Inc.(REAL)1,270,0000-1,270,000$3.99M$0—-$3.99M
Vaxcyte, Inc.(PCVX)72,0000-72,000$8.23M$0—-$8.23M
Vericel Corporation(VCEL)68,0000-68,000$2.87M$0—-$2.87M
VSee Health, Inc.W EXP 99 99 999(VSEE)150,0000-150,000$6.0K$0—-$6.0K
Wearable Devices LtdW EXP 09 14 2021,411,6000-1,411,600$28.1K$0—-$28.1K
Cycurion, Inc.W EXP 99 99 999(CYCU)100,0000-100,000$2.2K$0—-$2.2K
Page 1 of 1
Altium Capital Management LLC — 13F Holdings — Q4 2024 | TickerTrail